Related Content

• Conditions (11): Achalasia, Myasthenia Gravis, Parkinson's Disease, and 8 others Achalasia, Myasthenia Gravis, Parkinson's Disease, Peptic Ulcer, Genetic and Rare Conditions, Intestinal Obstruction, Bladder neck obstruction, Abnormalities, Drug-Induced, Esophageal Diseases, Multiple Sclerosis, Gastrointestinal Diseases [hide]
• Groups (3): Achalasia, Myasthenia Gravis, Parkinson's Disease Achalasia, Myasthenia Gravis, Parkinson's Disease [hide]
• Symptoms (8): Hypersensitivity, Pupillary Dilation function, Decreased Respiratory Secretions, and 5 others Hypersensitivity, Pupillary Dilation function, Decreased Respiratory Secretions, Positive Chronotropy, Salivation Inhibition, Achalasia, Myasthenia Gravis, Immediate hypersensitivity [hide]
• Treatments (26): Benztropine 1 MG Oral Tablet, Scopolamine, BENZTROPINE MESYLATE 1 MG, and 23 others Benztropine 1 MG Oral Tablet, Scopolamine, BENZTROPINE MESYLATE 1 MG, Benztropine 1 MG/ML Injectable Solution, Trihexyphenidyl Hydrochloride, Benztropine 0.5 MG Oral Tablet, URINARY ANTISEPTIC W/METHENAMINE 40.8MG/GELSEMIUM/AZOPHEN TAB, Scopolamine 0.4 MG/ML Injectable Solution, Trihexyphenidyl 2 MG Oral Tablet, Benztropine, Benztropine 2 MG Oral Tablet, URINARY ANTISEPTIC W/METHENAMINE 40.8MG/GELSEMIUM TAB, 24 HR Scopolamine 0.0138 MG/HR Transdermal Patch, Belladonna Alkaloids 0.13 MG / Phenobarbital 16.2 MG Oral Capsule, BELLADONNA ALKALOIDS 0.1296MG/SIMETHICONE 40MG LIQUID,ORAL, BENZTROPINE MESYLATE 0.5 MG, URISAL TAB, BENZTROPINE MESYLATE 1 MG/ML, BENZTROPINE MESYLATE 2 MG, Belladonna Alkaloids 0.203 MG Oral Tablet, Belladonna Alkaloids 0.026 MG/ML / Phenobarbital 3.24 MG/ML Elixir, Ergotamine 0.3 MG / Hyoscyamine 0.1 MG / Phenobarbital 20 MG Oral Tablet, Hyoscyamine 0.13 MG / Phenobarbital 16.2 MG Oral Tablet, Scopolamine Hydrobromide, Antiparkinson Agents, Belladonna Alkaloids 0.00672 MG/ML Oral Suspension [hide]

About Benzatropine Methanesulfonate

A synthetic antiparkinson tertiary amine structurally related to atropine, Benztropine Mesylate acts as a central muscarinic antagonist and inhibits dopamine uptake. With antihistaminic and local anesthetic properties as well, it is indicated for symptomatic relief of parkinsonism and drug-induced... more

A synthetic antiparkinson tertiary amine structurally related to atropine, Benztropine Mesylate acts as a central muscarinic antagonist and inhibits dopamine uptake. With antihistaminic and local anesthetic properties as well, it is indicated for symptomatic relief of parkinsonism and drug-induced extrapyramidal reactions. (NCI04)

less